Implementing a Multicomponent Intervention to Treat Blood Donors With Familial Hypercholesterolemia
Status: Recruiting
Location: See location...
Intervention Type: Other, Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
• Age 18 to 75 years
Locations
United States
Texas
UT Southwestern Medical Center
RECRUITING
Dallas
Contact Information
Primary
Amit Khera, MD
Amit.Khera@UTSouthwestern.edu
214.645.7500
Backup
Lakeisha Cade
Lakeisha.Cade@UTSouthwestern.edu
214.648.2878
Time Frame
Start Date: 2023-02-27
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 100
Treatments
Other: Control group (Usual care)
This arm will receive standard notification that is usually provided by Carter describing need to review with donor's primary care physician the presence of high cholesterol
Experimental: Intervention Group (Implementation strategy bundle)
Along with standard high cholesterol notification from Carter BloodCare, this arm will receive Implementation strategy bundle (educational material regarding high cholesterol levels)
Related Therapeutic Areas
Sponsors
Leads: University of Texas Southwestern Medical Center
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)